Philip Kam Tao LiSunita BavanandanRosmawati MohamedCheuk Chun SzetoVincent Wai Sun WongKai Ming ChowYock Young DanChiu Ching HuangChing Lung LaiTawesak TanwandeeBoon Wee TeoGrace Lai Hung WongEng Kiong YeohKunitoshi IsekiChi Bon LeungHyeong Cheon ParkTalerngsak KanjanabuchWanhong LuJames FungJidong JiaEiichiro KandaMan Ching LawHong LiuChing Kong LooSiu Ka MakSing Leung LuiHon Lok TangAngela Yee Moon WangMing Lung YuMichael CheungMichel JadoulThe University of Hong Kong, State Key Laboratory of Liver ResearchSeverance HospitalBeijing Friendship Hospital, Capital Medical UniversityKaohsiung Medical University Chung-Ho Memorial HospitalChina Medical University Hospital TaichungNational University Hospital, SingaporeUniversity of MalayaChulalongkorn UniversityYong Loo Lin School of MedicineKuala Lumpur HospitalPrince of Wales Hospital Hong KongKwong Wah HospitalXi'an Jiaotong UniversityCentral South UniversityPrincess Margaret Hospital Hong KongCliniques Universitaires Saint-LucFaculty of Medicine, Siriraj Hospital, Mahidol UniversityTung Wah HospitalKawasaki Medical CollegeThe University of Hong KongChinese University of Hong KongKidney Disease: Improving Global Outcomes (KDIGO)Tomishiro Central Hospital2020-08-252020-08-252020-08-01Kidney International Reports. Vol.5, No.8 (2020), 1129-1138246802492-s2.0-85088255142https://repository.li.mahidol.ac.th/handle/20.500.14594/58053© 2020 International Society of Nephrology In 2018, Kidney Disease: Improving Global Outcomes (KDIGO) published a clinical practice guideline on the prevention, diagnosis, evaluation, and treatment of hepatitis C virus (HCV) infection in chronic kidney disease (CKD). The guideline synthesized recent advances, especially in HCV therapeutics and diagnostics, and provided clinical recommendations and suggestions to aid healthcare providers and improve care for CKD patients with HCV. To gain insight into the extent that the 2018 guideline has been adopted in Asia, KDIGO convened an HCV Implementation Summit in Hong Kong. Participants included nephrologists, hepatologists, and nurse consultants from 8 Southeast Asian countries or regions with comparable high-to-middle economic ranking by the World Bank: mainland China, Hong Kong, Japan, Malaysia, Singapore, South Korea, Taiwan, and Thailand. Through presentations and discussions, meeting participants described regional practice patterns related to the KDIGO HCV in CKD guideline, identified barriers to implementing the guideline, and developed strategies for overcoming the barriers in Asia and around the world.Mahidol UniversityMedicineConference PaperSCOPUS10.1016/j.ekir.2020.05.001